Biology and management of primary effusion lymphoma.

Blood
Kazuyuki ShimadaHitoshi Kiyoi

Abstract

Primary effusion lymphoma (PEL) is a rare B-cell malignancy that most often occurs in immunocompromised patients, such as HIV-infected individuals and patients receiving organ transplantation. The main characteristic of PEL is neoplastic effusions in body cavities without detectable tumor masses. The onset of the disease is associated with latent infection of human herpes virus 8/Kaposi sarcoma-associated herpes virus, and the normal counterpart of tumor cells is B cells with plasmablastic differentiation. A condition of immunodeficiency and a usual absence of CD20 expression lead to the expectation of the lack of efficacy of anti-CD20 monoclonal antibody; clinical outcomes of the disease remain extremely poor, with an overall survival at 1 year of ∼30%. Although recent progress in antiretroviral therapy has improved outcomes of HIV-infected patients, its benefit is still limited in patients with PEL. Furthermore, the usual high expression of programmed death ligand 1 in tumor cells, one of the most important immune-checkpoint molecules, results in the immune escape of tumor cells from the host immune defense, which could be the underlying mechanism of poor treatment efficacy. Molecular-targeted therapies for the activating pat...Continue Reading

References

Jan 1, 1978·Clinical Pharmacology and Therapeutics·W E Evans, C B Pratt
May 4, 1995·The New England Journal of Medicine·E CesarmanD M Knowles
Jun 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E SalloumJ Murren
Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·J J RussoP S Moore
Mar 12, 1998·American Journal of Hematology·E OksenhendlerG Mansour
Aug 13, 1998·The New England Journal of Medicine·D JonesJ C Aster
May 30, 2001·Leukemia & Lymphoma·A KlepfishA Schattner
Mar 29, 2002·The Hematology Journal : the Official Journal of the European Haematology Association·E BoulangerE Oksenhendler
Oct 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shin-Ichi NakatsukaKatsuyuki Aozasa
Aug 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Richard G JennerPaul Kellam
Oct 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cecelia SimonelliUmberto Tirelli
Jun 11, 2004·Proceedings of the National Academy of Sciences of the United States of America·Hittu Matta, Preet M Chaudhary
Oct 19, 2004·The American Journal of Surgical Pathology·Amy ChadburnDaniel M Knowles
Jul 5, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emmanuelle BoulangerEric Oksenhendler
Dec 20, 2005·The Journal of Pathology·Thomas F Schulz
Apr 16, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Adam Bryant, Sam Milliken
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Kristopher A SarosiekIzidore S Lossos
Sep 25, 2010·Nature Reviews. Cancer·Enrique A MesriChris Boshoff
May 17, 2011·The Lancet Oncology·Michelle A RudekRichard F Ambinder
May 18, 2012·Leukemia & Lymphoma·Jorge J CastilloJames N Butera
Jan 4, 2013·The American Journal of Surgical Pathology·Serge AlexanianSheeja T Pullarkat
May 16, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Benjamin J ChenScott J Rodig

❮ Previous
Next ❯

Citations

Oct 9, 2019·The American Journal of Dermatopathology·Andrea SagginiLucia Anemona
Aug 18, 2020·Annals of Hematology·Keisuke KidoguchiKoichi Ohshima
Apr 3, 2020·Scientific Reports·Ramakrishnan GopalakrishnanPreet M Chaudhary
Sep 5, 2020·Investigational New Drugs·Chie Ishikawa, Naoki Mori
Nov 11, 2020·Virchows Archiv : an International Journal of Pathology·Akira SatouShigeo Nakamura
Jan 26, 2021·Clinical Case Reports·Yosuke SazumiFumio Otsuka
Mar 4, 2021·Nature Reviews. Clinical Oncology·Max JanBenjamin L Ebert
Apr 3, 2021·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Mikinori UenoSeiji Okada
Jun 3, 2021·Viruses·Miroslava ŠudomováSherif T S Hassan
Jun 9, 2021·Molecular Carcinogenesis·Louna KaramRaghida Abou Merhi
Jul 6, 2021·Frontiers in Oncology·Ricardo Rivera-SotoBlossom Damania
Aug 26, 2021·Respirology Case Reports·Chi-Wei ShihChia-Hsin Liu
Nov 3, 2021·The Journal of General Virology·Mizuho KajikawaTaisei Kanamoto
Jun 30, 2021·Gastroenterology·Hsueh-Chien ChiangYih-Jyh Lin

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

© 2022 Meta ULC. All rights reserved